Association of TLL1 Polymorphism with Development of Hepatocellular Carcinoma after Hepatitis C Virus Eradication and Fibrosis Severity

被引：0
|
作者：
Miki, Daiki [1 ]
Kawaoka, Tomokazu [1 ]
Yuko, Nagaoki [1 ]
Hayes, Nelson [1 ]
Ono, Atsushi [1 ]
Nakahara, Takashi [1 ]
Murakami, Eisuke [1 ]
Yamauchi, Masami [1 ]
Tsuge, Masataka [1 ,2 ]
Hiramatsu, Akira [1 ]
Imamura, Michio [1 ]
Aikata, Hiroshi [1 ]
Abe-Chayama, Hiromi [1 ,3 ]
Ochi, Hidenori [1 ,4 ]
Tsunoda, Tatsuhiko [5 ,6 ]
Chayama, Kazuaki [1 ,7 ,8 ]
机构：
[1] Hiroshima Univ, Dept Gastroenterol & Metab, Hiroshima, Japan
[2] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan
[3] Hiroshima Univ, Inst Biomed & Hlth Sci, Ctr Med Specialist Grad Educ & Res, Hiroshima, Japan
[4] Chuden Hosp, Hiroshima, Japan
[5] Riken Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan
[6] Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo, Japan
[7] Riken Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan
[8] Hiroshima Univ, Res Ctr Hepatol & Gastroenterol, Hiroshima, Japan
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1025
引用
收藏
页码：597A / 597A
页数：1
相关论文
共 50 条
  • [31] Hepatocellular carcinoma risks of liver fibrosis changes after viral eradication in chronic hepatitis C patients
    Liu, Yen-Chun
    Hsu, Cheng Er
    Cheng, Ya-Ting
    Su, Chung-Wei
    Tai, Chia-Hung
    Chen, Yi-Cheng
    Teng, Wei
    Jeng, Rachel Wen-Juei
    Lin, Chun-yen
    Chien, Rong-Nan
    Dar-In, Tai
    Sheen, I-Shyan
    JOURNAL OF HEPATOLOGY, 2022, 77 : S576 - S577
  • [32] Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C
    Tanaka, Atsushi
    Uegaki, Satoko
    Kurihara, Hiroko
    Aida, Kiyoshi
    Mikami, Masaki
    Nagashima, Ikuo
    Shiga, Junji
    Takikawa, Hajime
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (39) : 5180 - 5187
  • [33] Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?
    Nabatchikova, Ekaterina
    Abdurakhmanov, Dzhamal
    Rozina, Teona
    Nikulkina, Elena
    Tanaschuk, Elena
    Moiseev, Sergey
    JOURNAL OF HEPATOLOGY, 2020, 73 (02) : 469 - 470
  • [34] Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C
    Atsushi Tanaka
    Satoko Uegaki
    Hiroko Kurihara
    Kiyoshi Aida
    Masaki Mikami
    Ikuo Nagashima
    Junji Shiga
    Hajime Takikawa
    World Journal of Gastroenterology, 2007, (39) : 5180 - 5187
  • [35] PNPLA3andHLA-DQB1polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradication
    Miki, Daiki
    Akita, Tomoyuki
    Kurisu, Akemi
    Kawaoka, Tomokazu
    Nakajima, Tomoaki
    Hige, Shuhei
    Karino, Yoshiyasu
    Toyoda, Hidenori
    Kumada, Takashi
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Aikata, Hiroshi
    Hayes, Clair Nelson
    Honda, Koichi
    Seike, Masataka
    Akuta, Norio
    Kobayashi, Mariko
    Kumada, Hiromitsu
    Tanaka, Junko
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2020, 55 (12) : 1162 - 1170
  • [36] Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
    D'Ambrosio, Roberta
    Ioannou, George N.
    HEPATOLOGY COMMUNICATIONS, 2021, 5 (09) : 1465 - 1468
  • [37] Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development
    Nakamoto, Shingo
    Imazeki, Fumio
    Fukai, Kenichi
    Fujiwara, Keiichi
    Arai, Makoto
    Kanda, Tatsuo
    Yonemitsu, Yutaka
    Yokosuka, Osamu
    JOURNAL OF HEPATOLOGY, 2010, 52 (01) : 72 - 78
  • [38] Interleukin 1β gene polymorphism and hepatitis C virus-related hepatocellular carcinoma
    Yeo, AET
    Tanaka, Y
    Furuta, T
    HEPATOLOGY, 2003, 38 (01) : 267 - 268
  • [39] Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy
    Tong, MJ
    Lai, LP
    MurakamiMori, K
    WESTERN JOURNAL OF MEDICINE, 1997, 167 (02): : 103 - 105
  • [40] Chronological changes in FIB-4 and hepatocellular carcinoma development in patients with chronic hepatitis C after successful virus eradication
    Genda, Takuya
    Murata, Ayato
    Amano, Nozomi
    Sato, Sho
    Tsuzura, Hironori
    Sato, Shunsuke
    Narita, Yutaka
    Kanemitsu, Yoshio
    Shimada, Yuji
    Iijima, Katsuyori
    Nagahara, Akihito
    Watanabe, Sumio
    HEPATOLOGY, 2016, 64 : 380A - 381A
12345